7/25/2019 2. Prof. Harryanto - PERSONALIZED MED +MULTIDICIPLINE

1/6

Breast ca stage IV per mo

Paclitaxel $ 160

Gimsatabin $3,920

Albuminbound Paclitaxel $5,556

Docetaxel /Bewacizumab $ 11,106

ONCOLOGY ANALYTIC 2011

3

7/25/2019 2. Prof. Harryanto - PERSONALIZED MED +MULTIDICIPLINE

2/6

COLORECTAL CA STAGE IV

FOLFIRI + BEVACIZUMAB $ 4,381

FOLFOX + BEVACIZUMAB $8,014

FOLFIRI + CETUXIMAB $ 8,278

FOLFOX + CETUXIMAB $ 11,734

ONCOLOGY ANALYTIC 2011

4

7/25/2019 2. Prof. Harryanto - PERSONALIZED MED +MULTIDICIPLINE

3/6

Diteliti 301 Pasien terdiri darai 29 pasien kankerparu,119pasien kanker payudara ,65 pasienkanker kolon, Jumlah pasien kontrol adalah 6745

orang sehat .Ternyata pada pasien pasien kankeryang diteliti terdapat komorbit sbb:hipertensi 24-48%,penyakit koroner 8-024%,a nggine pectoris4-105,IMFARK MIOKARD 8-31%,ARITMIA 8-

195,STROKE 3-8%,emfise=ma 4-10% asma 5-12%,diabetes mellitus 8-18%,brokitis8-13%gagalgijal3-6%,penyakitsendi yang berat 34-57%.

7/25/2019 2. Prof. Harryanto - PERSONALIZED MED +MULTIDICIPLINE

4/6

Early Stage Cancers

7/25/2019 2. Prof. Harryanto - PERSONALIZED MED +MULTIDICIPLINE

5/6

COST EFFECTIVE/

individual Tailored/

Suvival,Socio economy

Age,Value,Belief ect

8

7/25/2019 2. Prof. Harryanto - PERSONALIZED MED +MULTIDICIPLINE

6/6